Downregulation of CD138, which is one of the early markers of apoptosis in myeloma cells and the percentage of CD38+/CD138Bright primary MM cells[16] as well as the amount of viable, apoptotic and dead cells were assessed simultaneously by flow cytometry (Fig 4). This evidence concerns the gene CD38 and Miyoshi myopathy.